Black tea polyphenols restrict benzopyrene-induced mouse lung cancer progression through inhibition of Cox-2 and induction of caspase-3 expression

Asian Pacific Journal of Cancer Prevention

Volumn 7, Issue 4, 2006, Pages 661-666

  Banerjee, Sarmistha ^a   Manna, Sugata ^a   Mukherjee, Sudeshna ^a   Pal, Debalina ^a   Panda, Chinmay Kr ^a   Das, Sukta ^a  

^a Chittarajan National Cancer Institute   (India)

Author keywords

Caspase 3; Caspase 7; Chemoprevention; Cox 2; Epigallocatechin gallate; Gene expression; Lung carcinogenesis; Theaflavins

Indexed keywords

BENZO[A]PYRENE DERIVATIVE; BIFLAVONOID; CASPASE 3; CATECHIN; CYCLOOXYGENASE 2; DRUG DERIVATIVE; EPIGALLOCATECHIN GALLATE; FLAVONOID; PHENOL DERIVATIVE; POLYPHENOLS; THEAFLAVIN; UNCLASSIFIED DRUG;

ANIMAL; ARTICLE; CELL PROLIFERATION; CHEMICALLY INDUCED DISORDER; CHEMISTRY; DISEASE COURSE; DRUG EFFECT; LUNG TUMOR; METABOLISM; MOUSE; NEWBORN; TEA; WESTERN BLOTTING;

ANIMALS; ANIMALS, NEWBORN; BENZOPYRENES; BIFLAVONOIDS; BLOTTING, WESTERN; CASPASE 3; CATECHIN; CELL PROLIFERATION; CYCLOOXYGENASE 2; DISEASE PROGRESSION; FLAVONOIDS; LUNG NEOPLASMS; MICE; PHENOLS; TEA;

EID: 33947542075     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Ahmad N, Hassan M (1999). Green tea polyphenols and cancer: Biological mechanisms and practical implications. Nutr Rev, 57, 78-83.
2. Balentinc DA (1992). Manufacturing and chemistry of tea. In: Huang MT, Ho CT, Lee CY (editors): Phenolic Compounds in Food and their Effects on Health,Washington DC: ACS; pp. 103-17.
3. Banerjee S, Das S (2004). Chemopreventive efficacy of black tea on benzo(a)pyrene induced lung carcinogenesis. Int J Cancer Prev, 1, 129-36.
4. Banerjee S, Manna S, Saha P, Panda CK, Das S (2005). Black tea polyphenols suppress cell proliferation and induce apoptosis during benzo(a)pyrene induced lung carcinogenesis. Eur J Cancer Prev, 14, 215-21.
5. Barge RM, Willemze R, Vandenabeele P, Fiers W, Beyaert R (1997). Differential involvement of caspases in apoptosis of myeloid leukemic cells induced by chemotherapy versus growth factor withdrawal. FEBS Lett, 409, 207-10.
6. Boring CC, Squires TS, Heath CW (1992). Cancer statistics for African Americans. CA Cancer J Clin, 42, 7-19.
7. Chandler JM, Cohen GM, MacFarlane M (1998). Different subcellular distribution of caspase-3 and caspase-7 following Fas-induced apoptosis in mouse liver. J Biol Chem, 273, 10815-8.
8. Chen C, Shen G, Hebbar V, et al. (2003). Epigallocatechin-3- gallate induced stress signal in HT-29 human colon adenocarcinoma cells. Carcinogenesis, 24, 1369-78.
9. Chen C, Yu R, Owuor ED, Kong AN (2000). Activation of antioxidant- response element (ARE), mitogen-activated protein kinases (MAPKs) and caspases by major green tea polyphenol components during cell survival and death. Arch Pharm Res, 23, 605-12.
10. Cohen GM (1997). Caspases: the executioners of apoptosis. Biochem J, 326, 1-16.
11. Chung FL, Wang M, Rivenson A, et al. (1998). Inhibition of lung tumorigenesis by black tea in Fischer rats treate with a tobacco specific carcinogen: caffein as important constituent. Cancer Res, 58, 244-8.
12. Dannenberg AJ, Subbaramaiah K (2003). Targeting cyclooxygenase- 2 in human neoplasia: rationale and promise. Cancer Cell, 4, 431-6.
13. Das S, Banerjee S, Saha P (2004). The models for assessment of chemopreventive agents: single organ models. Asian Pac JCancer Prev, 5, 15-23.
14. Dohadwala M, Batra RK, Luo J, et al. (2002). Autocrine/paracrine prostaglandin E2 production by non-small cell lung cancer cells regulates matrix metalloproteinase-2 and CD44 in cyclooxygenase-2-dependent invasion. J Biol Chem, 277, 50828-33.
15. Dohadwala M, Luo J, Zhu L, et al. (2001). Non-small cell lung cancer cyclooxygenase-2-dependent invasion is mediated by CD44. J Biol Chem, 276, 20809-12.
16. Duan H, Chinnaiyan AM, Hudson PL, et al. (1996). ICE-LAP3, a novel mammalian homologue of the caenorhabditis elegans cell death protein ced-3 is activated during fas- and tumor necrosis factor-induced apoptosis. J Biol Chem, 271, 1621-5.
17. Dubinett SM, Sharma S, Huang M, et al. (2003). Cyclooxygenase-2 in lung cancer. Prog Exp Tumor Res, 37, 138-62.
18. Fernandes-Alnemri T, Takahashi A, Armstrong R, et al. (1995). Mch3, a novel human apoptotic cysteine protease highly related to CPP32. Cancer Res, 55, 6045-52.
19. Fujiki H, Suganuma M, Okabe S (1999). Mechanistic findings of green tea as cancer preventive for humans. Proc Soc Exp Biol Med, 220, 225-8.
20. Hayakawa S, Saeki K, Sazuka M, et al. (2001). Apoptosis induction by epigallocatechin gallate involves its binding to Fas. Biochem Biophys Res Commun, 285, 1102-6.
21. Hecht SS, Camella SG, Murphy SE, Foiles PG, Chung FL (1993). Carcinogen biomarkers related to smoking and upper aerodigestive tract. Cancer J Cell Biochem, 17F, 27-35.
22. Hecht SS, Hoffmann D (1988). Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke. Carcinogenesis, 9, 875-84.
23. Islam S, Islam N, Kermode T, et al. (2000). Involvement of caspase-3 in epigallocatechin -3-gallate- mediated apoptosis of human chondrosarcoma cells. Biochem Biophys Res Commun, 270, 793-7.
24. Jhawar RS (2000). Tea the Universal Health Drink; UBS Publishers, New Delhi, 67.
25. Katiyar SK, Mukhtar H (1996). Tea in chemoprevention of cancer: epidemiology and experimental studies. Int J Oncol, 8, 221-38.
26. Kelley DJ, Mestre JR, Subbaramaiah K, et al. (1997). Benzo(a)pyrene up-regulates cyclooxygenase-2 gene expression in oral epithelial cells. Carcinogenesis, 18,795-9.
27. Kohlmeier L, Weterings KGC, Steek S, Kok FJ (1997). Tea and cancer prevention: an evaluation of the epidemiologic literature. Nutr Cancer, 27, 1-13.
28. Krysan K, Merchant FH, Zhu L, et al. (2004). COX-2-dependent stabilization of survivin in non-small cell lung cancer. FASEB J, 18, 206-8.
29. Kumar S (1995). ICE-like proteases in apoptosis. Trends Biochem Sci, 20, 198-202.
30. Lu J, Ho CT, Ghai G, Chen YK (2000). Differential effects of theaflavin monogallates on cell growth, apoptosis, and Cox-2 gene expression in cancerous versus normal cells. Cancer Res, 60, 6465-71.
31. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ (1951). Protein measurement with the Folin phenol reagent. J Biol Chem, 193, 265-76.
32. MacFarlane M, Cain K, Sun XM, Alnemri ES, Cohen GM (1997). Processing/activation of at least four interleukin-1beta converting enzyme-like proteases occurs during the execution phase of apoptosis in human monocytic tumor cells. J Cell Biol, 137, 469-79.
33. McVicar DW, Taylor LS, Gosselin P, et al. (1998). DAP12-mediated signal transduction in natural killer cells: a dominant role for the syk protein-tyrosine kinase. J Biol Chem, 273, 32934-42.
34. Nicholson DW, Thornberry NA (1997). Caspases: killer proteases. Trends Biochem Sci, 22, 299-306.
35. Nicholson DW, Ali A, Thornberry NA, et al. (1995). Identification and inhibition of the ice/ced-3 protease necessary for mammalian apoptosis. Nature, 376, 37-43.
36. Parkin DM, Bray FI, Devesa SS (2001). Cancer burdens in the year 2000. The global picture. Eur J Cancer, 37, S4-66.
37. Patel T, Gores GJ, Kaufmann SH (1996). The role of proteases during apoptosis. FASEB J, 22, 299-306.
38. Population Based Cancer Registry, Report Kolkata (1997-2001). Chittaranjan National Cancer Institute, Kolkata.
39. Saha P, Das S (2002). Elimination of deleterious effects of free radicals in murine skin carcinogenesis by black tea infusion, theaflavins and epigallocatechin gallate. Asian Pac J Cancer Prev, 3, 225-30.
40. Sengupta A, Ghosh S, Das S (2003). Tea can protect against aberrant crypt foci formation during azoxymethane induced rat colon carcinogenesis. J Exp Clin Cancer Res, 22, 421-7.
41. Stoner GD, Mukhtar H (1995). Polyphenols as cancer chemopreventive agents (review). J Cell Biochem. 22 Suppl, 169-80.
42. Subbaramaiah K, Telang N, Ramonetti JT, et al. (1996). Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells. Cancer Res, 56, 4424-9.
43. Thornberry NA, Rano TA, Peterson EP, et al. (1997). A combinatorial approach defines specificities of members of the caspase family and granzyme b: functional relationships established for key mediators of apoptosis. J Biol Chem, 272, 17907-11.
44. Tormanen-Napankangas U, Soini Y, Kahlos K, Kinnula V, Paakko P (2001). Expression of caspase-3,-6 and -8 and their relation to apoptosis in non-small cell carcinoma. Int J Cancer, 93, 192-8.
45. Tsujii M, DuBois RN (1995) Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell, 83, 493-501.
46. Yamaoka K, Otsuka T, Niiro H, Arinobu Y, Niho Y, Hamasaki N, Izuhara K (1998). Activation of STAT5 by lipopolysaccharide through granulocyte-macrophage colony-stimulating factor production in human monocytes. J Immunol, 160, 838-45.
47. Yang J, Liu X, Bhalla K, et al. (1997). Prevention of apoptosis by bcl-2: release of cytochrome c from mitochondria blocked. Science, 275, 1129-32.
48. Yun T-K, Sung-Ho K, Yun-Sil L (1995). Trial of a new mediumterm model using benzo(a)pyrene induced lung tumor in newborn mice. Anticancer Res, 15, 839-46.
49. Zedeck MS (1980). Polycyclic aromatic hydrocarbons, a review. J Environ Pathol Toxicol, 3, 537.